Your browser doesn't support javascript.
loading
Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
Anjali Ramaswamy; Nina N. Brodsky; Tomokazu S. Sumida; Michela Comi; Hiromitsu Asashima; Kenneth B. Hoehn; Ningshan Li; Yunqing Liu; Aagam Shah; Neal G. Ravindra; Jason Bishai; Alamzeb Khan; William Lau; Brian Sellers; Neha Bansal; Rachel Sparks; Avraham Unterman; Victoria Habet; Andrew J. Rice; Jason Catanzaro; Harsha Chandnani; Merrick Lopez; Naftali Kaminski; Charles S. Dela Cruz; John S. Tsang; Zuoheng Wang; Xiting Yan; Steven H. Kleinstein; David van Dijk; Richard W. Pierce; David A. Hafler; Carrie L. Lucas.
Afiliação
  • Anjali Ramaswamy; Department of Immunobiology, Yale University School of Medicine
  • Nina N. Brodsky; Department of Immunobiology, Yale University School of Medicine; Department of Pediatrics, Yale University School of Medicine
  • Tomokazu S. Sumida; Department of Immunobiology, Yale University School of Medicine; Department of Neurology, Yale University School of Medicine
  • Michela Comi; Department of Immunobiology, Yale University School of Medicine; Department of Neurology, Yale University School of Medicine
  • Hiromitsu Asashima; Department of Immunobiology, Yale University School of Medicine; Department of Neurology, Yale University School of Medicine
  • Kenneth B. Hoehn; Department of Pathology, Yale University School of Medicine
  • Ningshan Li; Department of Biostatistics, Yale School of Public Health
  • Yunqing Liu; Department of Biostatistics, Yale School of Public Health
  • Aagam Shah; Department of Internal Medicine (Cardiology), Yale University School of Medicine; Department of Computer Science, Yale University
  • Neal G. Ravindra; Department of Internal Medicine (Cardiology), Yale University School of Medicine; Department of Computer Science, Yale University
  • Jason Bishai; Department of Internal Medicine (Cardiology), Yale University School of Medicine; Department of Computer Science, Yale University
  • Alamzeb Khan; Department of Pediatrics, Yale University School of Medicine
  • William Lau; NIH Center for Human Immunology (CHI), NIH; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH.
  • Brian Sellers; NIH Center for Human Immunology (CHI), NIH
  • Neha Bansal; NIH Center for Human Immunology (CHI), NIH; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH
  • Rachel Sparks; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH
  • Avraham Unterman; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine
  • Victoria Habet; Department of Pediatrics, Yale University School of Medicine
  • Andrew J. Rice; Department of Immunobiology, Yale University School of Medicine
  • Jason Catanzaro; Department of Pediatrics, Yale University School of Medicine
  • Harsha Chandnani; Department of Pediatrics, Loma Linda School of Medicine
  • Merrick Lopez; Department of Pediatrics, Loma Linda School of Medicine
  • Naftali Kaminski; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine
  • Charles S. Dela Cruz; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine
  • John S. Tsang; NIH Center for Human Immunology (CHI), NIH; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH.
  • Zuoheng Wang; Department of Biostatistics, Yale School of Public Health
  • Xiting Yan; Department of Biostatistics, Yale School of Public Health; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine
  • Steven H. Kleinstein; Department of Pathology, Yale University School of Medicine; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University
  • David van Dijk; Department of Internal Medicine (Cardiology), Yale University School of Medicine; Department of Computer Science, Yale University
  • Richard W. Pierce; Department of Pediatrics, Yale University School of Medicine
  • David A. Hafler; Department of Immunobiology, Yale University School of Medicine; Department of Neurology, Yale University School of Medicine
  • Carrie L. Lucas; Department of Immunobiology, Yale University School of Medicine
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20241364
ABSTRACT
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children. Here, we define immune abnormalities in MIS-C compared to adult COVID-19 and pediatric/adult healthy controls using single-cell RNA sequencing, antigen receptor repertoire analysis, unbiased serum proteomics, and in vitro assays. Despite no evidence of active infection, we uncover elevated S100A-family alarmins in myeloid cells and marked enrichment of serum proteins that map to myeloid cells and pathways including cytokines, complement/coagulation, and fluid shear stress in MIS-C patients. Moreover, NK and CD8 T cell cytotoxicity genes are elevated, and plasmablasts harboring IgG1 and IgG3 are expanded. Consistently, we detect elevated binding of serum IgG from severe MIS-C patients to activated human cardiac microvascular endothelial cells in culture. Thus, we define immunopathology features of MIS-C with implications for predicting and managing this SARS-CoV2-induced critical illness in children.
Licença
cc_no
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...